OverviewChartNewsTraderScreen

Soc. Generale Knock-Out BION/  DE000SU1NBH7  /

Frankfurt Zert./SG
21/06/2024  21:48:13 Chg.+0.050 Bid21:51:46 Ask21:51:46 Underlying Strike price Expiration date Option type
0.260EUR +23.81% 0.270
Bid Size: 10,000		 0.330
Ask Size: 10,000		 BB BIOTECH N 36.7103 CHF 31/12/2078 Call
GlobeNewswire 02/04 Abivax reports 2023 financial results and operational update
GlobeNewswire 28/03 Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire 27/11/2023 Arvinas Announces Oversubscribed $350 Million Private Placement
GlobeNewswire 08/03/2022 NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
GlobeNewswire 17/06/2021 Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
TeleTrader 15/04/2021 Incidence of blood clots in Pfizer, Moderna, AZ vaccines similar- report
TeleTrader 14/04/2021 EU to get 50M Pfizer COVID vaccines in Q2 rather than Q4
TeleTrader 11/11/2020 Pfizer, BioNTech grant EU 200 million vaccine doses
GlobeNewswire 16/12/2019 Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire 19/10/2018 Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire 02/01/2018 Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire 06/12/2017 Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
GlobeNewswire 19/10/2017 Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire 02/12/2016 Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire 21/10/2016 Biotech stocks continue to advance
GlobeNewswire 11/10/2016 BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 11/10/2016 Ad hoc: BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 29/07/2016 Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire 22/07/2016 BB Biotech: Stabilization of biotech sector in the second quarter of 2016
GlobeNewswire 15/07/2016 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 14/07/2016 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
GlobeNewswire 11/07/2016 BB Biotech AG with after-tax loss in the first half year of 2016
GlobeNewswire 23/06/2016 BB Biotech AG :Release of the Home Member State according to Article 2c of the WpHG (the German Secu...
GlobeNewswire 22/04/2016 BB BIOTECH AG: Challenging first quarter for biotech investments
GlobeNewswire 13/04/2016 BB Biotech AG with after-tax loss in the first quarter of 2016